Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a revision entry for v3.5.0 and removed the v3.4.3 entry from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T21:09:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.6%
    Check dated 2026-02-11T10:20:10.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:12:53.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and color-coded highlights to distinguish additions and deletions, improving readability of changes. It also displays revision notes (such as v3.4.0) and removes the previous No FEAR Act labeling.
    Difference
    0.8%
    Check dated 2026-01-28T05:53:21.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The update shows a small revision-history change, with Revision: v3.3.4 being added and Revision: v3.3.3 removed from the log. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:25:25.000Z thumbnail image

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.